2-[[4-(acridin-4-yloxy)butyl]-(2-hydroxyethyl)amino]ethanol | 898833-87-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-[[4-(acridin-4-yloxy)butyl]-(2-hydroxyethyl)amino]ethanol
• 英文别名: 2-[4-Acridin-4-yloxybutyl(2-hydroxyethyl)amino]ethanol
• CAS: 898833-87-9
• 化学式: C₂₁H₂₆N₂O₃
• 分子量: 354.449
• InChiKey: CPMVWMLQZOHGQN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  26
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  65.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-[[4-(acridin-4-yloxy)butyl]-(2-hydroxyethyl)amino]ethanol 在 甲基磺酰氯 、 三乙胺 作用下， 以 氯仿 为溶剂， 反应 72.0h， 生成 4-acridin-4-yloxy-N,N-bis(2-chloroethyl)butan-1-amine
  参考文献：
  名称：

  Potent Antitumor 9-Anilinoacridines and Acridines Bearing an Alkylating N-Mustard Residue on the Acridine Chromophore:  Synthesis and Biological Activity

  摘要：

  A series of 9-anilinoacridine and acridine derivatives bearing an alkylating N-mustard residue at C4 of the acridine chromophore were synthesized. The N-mustard pharmacophore was linked to the C4 of the acridine ring with an O-ethyl ( O-C-2), O-propyl ( O-C-3), or O-butyl ( O-C-4) spacer. It revealed that all newly synthesized compounds were very potent cytotoxic agents against human leukemia and various solid tumors in vitro. These agents did not exhibit cross-resistance against vinblastine-resistant ( CCRF-CEM/VBL) or taxol-resistant ( CCRF-CEM/taxol) cells. It also showed that these agents were DNA cross-linking agents rather than topoisomerase II inhibitors. Of these agents, compounds 27a and 27c were shown to have potent antitumor activity in nude mice bearing the human breast carcinoma MX-1 xenograft. The therapeutic efficacies of these two agents are comparable to that of taxol.

  DOI：

  10.1021/jm060197r
• 作为产物：
  描述：

  4-羟基吖啶 在 potassium carbonate 作用下， 以 二乙二醇二甲醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.5h， 生成 2-[[4-(acridin-4-yloxy)butyl]-(2-hydroxyethyl)amino]ethanol
  参考文献：
  名称：

  Potent Antitumor 9-Anilinoacridines and Acridines Bearing an Alkylating N-Mustard Residue on the Acridine Chromophore:  Synthesis and Biological Activity

  摘要：

  A series of 9-anilinoacridine and acridine derivatives bearing an alkylating N-mustard residue at C4 of the acridine chromophore were synthesized. The N-mustard pharmacophore was linked to the C4 of the acridine ring with an O-ethyl ( O-C-2), O-propyl ( O-C-3), or O-butyl ( O-C-4) spacer. It revealed that all newly synthesized compounds were very potent cytotoxic agents against human leukemia and various solid tumors in vitro. These agents did not exhibit cross-resistance against vinblastine-resistant ( CCRF-CEM/VBL) or taxol-resistant ( CCRF-CEM/taxol) cells. It also showed that these agents were DNA cross-linking agents rather than topoisomerase II inhibitors. Of these agents, compounds 27a and 27c were shown to have potent antitumor activity in nude mice bearing the human breast carcinoma MX-1 xenograft. The therapeutic efficacies of these two agents are comparable to that of taxol.

  DOI：

  10.1021/jm060197r

文献信息

• Potent Antitumor 9-Anilinoacridines and Acridines Bearing an Alkylating <i>N</i>-Mustard Residue on the Acridine Chromophore:  Synthesis and Biological Activity
  作者：Tsann-Long Su、Yi-Wen Lin、Ting-Chao Chou、Xiuguo Zhang、Valeriy A. Bacherikov、Ching-Huang Chen、Leroy F. Liu、Tsong-Jen Tsai

  DOI：10.1021/jm060197r

  日期：2006.6.1

  A series of 9-anilinoacridine and acridine derivatives bearing an alkylating N-mustard residue at C4 of the acridine chromophore were synthesized. The N-mustard pharmacophore was linked to the C4 of the acridine ring with an O-ethyl ( O-C-2), O-propyl ( O-C-3), or O-butyl ( O-C-4) spacer. It revealed that all newly synthesized compounds were very potent cytotoxic agents against human leukemia and various solid tumors in vitro. These agents did not exhibit cross-resistance against vinblastine-resistant ( CCRF-CEM/VBL) or taxol-resistant ( CCRF-CEM/taxol) cells. It also showed that these agents were DNA cross-linking agents rather than topoisomerase II inhibitors. Of these agents, compounds 27a and 27c were shown to have potent antitumor activity in nude mice bearing the human breast carcinoma MX-1 xenograft. The therapeutic efficacies of these two agents are comparable to that of taxol.